Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 1810164 | Pemigatinib (INCB054828) | 1513857-77-6 | 98% |  |
| Pemigatinib (INCB054828) is an orally active, selectiveFGFRinhibitor withIC50s of 0.4 | ||||
| 189131 | Pelitrexol | 446022-33-9 | >98% |  |
| Pelitrexol is a GARFT inhibitor, and is also a water soluble antifolate with anti-pro | ||||
| 18943 | PCI-33380 | 1022899-36-0 | >98% |  |
| PCI-33380 was designed based on the ibrutinib scaffold and has been used in both cell | ||||
| 187164 | Perastine | 4960-10-5 | >98% |  |
| Perastine is a biochemical. | ||||
| 187125 | PCO371 | 1613373-33-3 | >98% |  |
| PCO371 is a potent and selective PTHR1 agonist for the treatment of hypoparathyroidis | ||||
| 18756 | PQR530 | 1927857-61-1 | >98% |  |
| PQR530 is a highly potent dual pan-PI3K/mTORC1/2 inhibitor. | ||||
| 18731 | Pyrotinib | 1269662-73-8 | >98% |  |
| Pyrotinibm, also known as SHR-1258, is an orally bioavailable, dual kinase inhibitor | ||||
| 186274 | PX20606 trans-isomer | 1268244-85-4 | >98% |  |
| PX20606, also known as PX-102, is a FXR agonist. | ||||
| 186153 | PF-05180999 | 1394033-54-5 | >98% |  |
| PF-05180999 is a potent and selective PDE2a inhibitor (PDE2a IC50 = 0.001 μM, 2000-f | ||||
| 186152 | Pritelivir mesylate | 1428333-96-3 | >98% |  |
| Pritelivir, also known as AIC-316 and BAY 57-1293, is a potent helicase primase inhib | ||||
| 18673 | Pridopidine | 346688-38-8 | >98% |  |
| Pridopidine, also known as ACR16, is a dopamine stabilizer, which improves motor perf | ||||
| 185233 | Pamiparib | 1446261-44-4 | 98% Min. |  |
| Pamiparib is an antineoplastic drug candidate.Pamiparib (BGB-290) is an investigation | ||||
| 185223 | PAC 14028 | 1005168-10-4 | >98% |  |
| PAC 14028, also known as Asivatrep, is a vanilloid VR1 receptor (TRPV1) antagonist po | ||||
| 185157 | PE859 | 1402727-29-0 | >98% |  |
| PE859 is a potent inhibitor of both tau and Aβ aggregation with IC50 values of 0.66 | ||||
| 185156 | PD 168 077 | 190383-31-4 | >98% |  |
| PD168077 is a dopamine D4 receptor agonist which has a facilitatory effect on memory | ||||
| 185155 | PF-06462894 | 1622291-66-0 | >98% |  |
| PF-06462894 is a morpholinopyrimidone mGlu5 (mGlu5 Ki = 6 nM). | ||||
| 185154 | PF-06291874 | 1393124-08-7 | >98% |  |
| PF-06291874 is a glucagon receptor antagonist and potentially usefully for patients w | ||||
| 185153 | Poseltinib | 1353552-97-2 | >98% |  |
| Poseltinib, also known HM-71224 and LY3337641, is a tyrosine kinase inhibitor. | ||||
| 185148 | Pibrentasvir | 1353900-92-1 | >98% |  |
| Pibrentasvir, also known as ABT-530, is a protease inhibitor potentially for the trea | ||||
| 185147 | PP2 Analog | 309739-67-1 | >98% |  |
| PP2 Analog is an analog of PP2 that acts as a protein trafficking modulator. | ||||
| 185146 | PP2 | 172889-27-9 | >98% |  |
| PP2, also known as AG 1879, is a substance that has frequently been used in cancer re | ||||
| 185145 | PP1 | 172889-26-8 | >98% |  |
| PP1 is a potent and selective Src family protein tyrosine kinase inhibitor. | ||||
| 185144 | Pocapavir | 146949-21-5 | >98% |  |
| Pocapavir, also known as SCH-48973 and V-073, is a potent, selective, antienterovirus | ||||
| 185143 | PSMA617 TFA | 1702967-37-0 | >98% |  |
| PSMA-617 is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to | ||||
| 185142 | Pyridostatin TFA salt | 1472611-44-1 | >98% |  |
| Pyridostatin stabilizes G-quadruplexes (G4s) in cells and elicits a DNA damage respon | ||||
| 18544 | PF-06260933 | 1811510-56-1 | >98% |  |
| PF-06260933 is a potent and highly selective inhibitor of MAP4K4. | ||||
| 184286 | PHA-767491 HCl | 942425-68-5 | >98% |  |
| PHA-767491, also known as CAY10572, is a potent, ATP-competitive dual cdc7/cdk9 inhib | ||||
| 184285 | PLX51107 | 1627929-55-8 | >98% |  |
| PLX51107 is a potent and selective BRD4 inhibitor or BET inhibitor with novel in vitr | ||||
| 184284 | PD 158780 | 171179-06-9 | >98% |  |
| PD 158780 is a potent in vitro inhibitor of the tyrosine kinase activity of the epide | ||||
| 184162 | PZM21 | 1997387-43-5 | >98% |  |
| PZM21 is a potent Gi activator with exceptional selectivity for μOR and minimal β-a | ||||